CD19 CAR T cells for adults with relapsed or refractory acute lymphoblastic leukaemia

被引：10
|
作者：
Maus, Marcela V. [1 ]
机构：
[1] Massachusetts Gen Hosp, Cellular Immunotherapy Program, Ctr Canc, Charlestown, MA 02129 USA
来源：
LANCET | 2021年 / 398卷 / 10299期
关键词：
B-CELL;
D O I：
10.1016/S0140-6736(21)01289-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：466 / 467
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of humanized anti-CD19-CAR-T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia
    Wang, Jia
    Mou, Nan
    Yang, Zhenxing
    Li, Qing
    Jiang, Yanyu
    Meng, Juanxia
    Liu, Xuxiang
    Deng, Qi
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (02) : 212 - 222
  • [42] Clonal evolution of acute myeloid leukaemia from T (12;21) acute lymphoblastic leukaemia under immunological selection imposed by CD19 CAR-T therapy
    Senthil, Srividhya
    Bonney, Denise
    Campbell, Helen
    Amrolia, Persis
    Wright, Gary
    Telford, Nicholas
    Wynn, Robert
    BONE MARROW TRANSPLANTATION, 2019, 54 : 518 - 518
  • [43] CD28-COSTIMULATED CD19 CAR T CELLS FOR PEDIATRIC RELAPSED AND REFRACTORY MATURE B-CELL LYMPHOMA
    Jacoby, Elad
    Adam, Etai
    Abramovich, Alon
    Shapira, Adi
    Hutt, Daphna
    Itzhaki, Orit
    Bielorai, Bella
    Toren, Amos
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 563 - 564
  • [44] CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia
    Holly L. Pacenta
    Theodore W. Laetsch
    Samuel John
    Pediatric Drugs, 2020, 22 : 1 - 11
  • [45] CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia
    Pacenta, Holly L.
    Laetsch, Theodore W.
    John, Samuel
    PEDIATRIC DRUGS, 2020, 22 (01) : 1 - 11
  • [46] HUMANIZED CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELTS TARGETING CD19 INDUCE REMISSIONS IN CHILDREN AND YOUNG ADULTS WITH RELAPSED/REFRACTORY LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
    Hucks, G. E.
    Barrett, D.
    Rheingold, S. R.
    Aplenc, R.
    Teachey, D. T.
    Callahan, C.
    Baniewicz, D.
    White, C.
    Talekar, M.
    Shaw, P.
    Brogdon, J. L.
    Young, R.
    Scholler, J.
    Marcucci, K.
    Chew, A.
    Levine, B. L.
    Frey, N.
    Porter, D.
    Lacey, S.
    Melenhorst, J.
    June, C.
    Grupp, S.
    Maude, S.
    CYTOTHERAPY, 2017, 19 (05) : S9 - S10
  • [47] CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Davila, Marco L.
    Brentjens, Renier J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 802 - 808
  • [48] CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS TARGETING CD19 INDUCE SUSTAINED REMISSIONS IN CHILDREN AND YOUNG ADULTS WITH RELAPSED/REFRACTORY ALL
    Maude, S.
    Shaw, P.
    Aplenc, R.
    Barrett, D.
    Barker, C.
    Callahan, C.
    Grupp, C.
    Lacey, S.
    Levine, B.
    Melenhorst, J.
    Motley, L.
    Rheingold, S.
    Teachey, D.
    June, C.
    Grupp, S.
    HAEMATOLOGICA, 2015, 100 : 6 - 6
  • [49] CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
    Molostova, Olga
    Shelikhova, Larisa
    Muzalevsky, Yakov
    Kazachenok, Alexey
    Khismatullina, Rimma
    Abugova, Julia
    Kurnikova, Elena
    Trakhtman, Pavel
    Pershin, Dmitry
    Zubachenko, Viktoria
    Fadeeva, Maria
    Popov, Alexander M.
    Illarionova, Olga
    Miakova, Natalia
    Litvinov, Dmitry
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2021, 138
  • [50] Outcome after relapse post cd19 car t-cells in children and young adults with relapsed/refractory b-cell precursor acute lymphoblastic leukemia (R/R B-ALL)
    Alonso-Saladrigues, A.
    Faura Morros, A.
    Catala Temprano, A.
    Pont Marti, S.
    Garcia Rey, E.
    Camos Guijosa, M.
    Dapena Diaz, J. L.
    Conde Cuevas, N.
    Isola, I. M.
    Vega-Garcia, N.
    Esperanza-Cebollada, E.
    Jordan Garcia, I.
    Bobillo Perez, S.
    Alsina-Manrique, L.
    Deya, A.
    Rivera-Perez, C.
    Marsal, J.
    Vinent-Genestar, J.
    Llanos Principe, C.
    Pedrals Portabella, G.
    Moron-Cazalilla, G.
    Juan, M.
    Torrebadell, M.
    Rives, S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 132 - 133
12345